Boston Scientific Corporation vs KLA Corp. — how do they compare? Boston Scientific Corporation trades at $50.96 (market cap $74.19B), while KLA Corp. trades at $204.6 (market cap $261.92B). The key difference: KLA Corp. is far larger — about 3.5× Boston Scientific Corporation's market cap, and KLA Corp. pays a 0.46% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | KLAC | |
|---|---|---|
Market Cap | $74.19B | $261.92B |
Sector | Health | Technology |
52-Week High | $108.14 | $301.71 |
52-Week Low | $42.63 | $84.39 |
Enterprise Value | $86.27B | $263.17B |
Dividend Yield | — | 0.46% |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →KLA designs and manufactures yield-management and process-monitoring diagnostic and control systems for the semiconductor manufacturing industry. The systems are used to analyze the manufacturing process at various steps in a semiconductor's development. The firm's laser-scanning products are used for wafer qualification, process monitoring, and equipment monitoring. KLA also provides inspection tools and systems for optical metrology and e-beam metrology.
Read more on KLAC →